Literature DB >> 2089133

Neuropathological study of the amygdala in presenile Alzheimer's disease.

K Tsuchiya1, K Kosaka.   

Abstract

We studied neuropathological changes of the amygdala in 10 cases of presenile Alzheimer's disease. According to the anatomical classification of the amygdala, we subdivided the corticomedial group into 3 parts, and the basolateral group into 8 parts. We investigated qualitatively neuronal loss, and quantitatively the numbers of neurofibrillary tangles (NFTs) and senile plaques (SPs) in 11 parts. The degree of atrophy of the amygdala was also checked in relation to the clinical stages of the disease. Neuronal loss was more prominent in the later clinical stages. It was more intense in the corticomedial group than in the basolateral group. The density of NFTs tended also to be greater in the corticomedial group than in the basolateral group, although it did not always increase in parallel with the progress of dementia. The density of SPs was greater in the basolateral group than in the corticomedial group, and tended to increase in parallel with the progress of the disease. Atrophy of the amygdala was generally more prominent in the more advanced clinical stage. The distribution pattern of neuronal loss was similar to that of NFTs in the amygdala, whereas the distribution pattern of SPs was quite different.

Entities:  

Mesh:

Year:  1990        PMID: 2089133     DOI: 10.1016/0022-510x(90)90029-m

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  20 in total

1.  Detergent Insoluble Proteins and Inclusion Body-Like Structures Immunoreactive for PRKDC/DNA-PK/DNA-PKcs, FTL, NNT, and AIFM1 in the Amygdala of Cognitively Impaired Elderly Persons.

Authors:  Jozsef Gal; Jing Chen; Yuriko Katsumata; David W Fardo; Wang-Xia Wang; Sergey Artiushin; Douglas Price; Sonya Anderson; Ela Patel; Haining Zhu; Peter T Nelson
Journal:  J Neuropathol Exp Neurol       Date:  2018-01-01       Impact factor: 3.685

2.  Pericapillary and distant axon terminals in the nuclei of the cat amygdala: a morphometric study.

Authors:  I Lukaszyk; M Kraszpulski; T Wrzołkowa
Journal:  Anat Embryol (Berl)       Date:  1996-03

3.  Amygdala Atrophy in MCI/Alzheimer's Disease in the BIOCARD cohort based on Diffeomorphic Morphometry.

Authors:  Michael I Miller; Laurent Younes; J Tilak Ratnanather; Timothy Brown; Tommy Reigel; Huong Trinh; Xiaoying Tang; Peter Barker; Susumu Mori; Marilyn Albert
Journal:  Med Image Comput Comput Assist Interv       Date:  2012-10

4.  Shape abnormalities of subcortical and ventricular structures in mild cognitive impairment and Alzheimer's disease: detecting, quantifying, and predicting.

Authors:  Xiaoying Tang; Dominic Holland; Anders M Dale; Laurent Younes; Michael I Miller
Journal:  Hum Brain Mapp       Date:  2014-01-17       Impact factor: 5.038

Review 5.  The Amygdala as a Locus of Pathologic Misfolding in Neurodegenerative Diseases.

Authors:  Peter T Nelson; Erin L Abner; Ela Patel; Sonya Anderson; Donna M Wilcock; Richard J Kryscio; Linda J Van Eldik; Gregory A Jicha; Zsombor Gal; Ruth S Nelson; Bela G Nelson; Jozsef Gal; Md Tofial Azam; David W Fardo; Matthew D Cykowski
Journal:  J Neuropathol Exp Neurol       Date:  2018-01-01       Impact factor: 3.685

6.  Alzheimer disease with amygdala Lewy bodies: a distinct form of alpha-synucleinopathy.

Authors:  Hirotake Uchikado; Wen-Lang Lin; Michael W DeLucia; Dennis W Dickson
Journal:  J Neuropathol Exp Neurol       Date:  2006-07       Impact factor: 3.685

7.  Amygdala atrophy is prominent in early Alzheimer's disease and relates to symptom severity.

Authors:  Stéphane P Poulin; Rebecca Dautoff; John C Morris; Lisa Feldman Barrett; Bradford C Dickerson
Journal:  Psychiatry Res       Date:  2011-09-14       Impact factor: 3.222

8.  Amygdalar atrophy in symptomatic Alzheimer's disease based on diffeomorphometry: the BIOCARD cohort.

Authors:  Michael I Miller; Laurent Younes; J Tilak Ratnanather; Timothy Brown; Huong Trinh; David S Lee; Daniel Tward; Pamela B Mahon; Susumu Mori; Marilyn Albert
Journal:  Neurobiol Aging       Date:  2014-08-29       Impact factor: 4.673

9.  BIOMARKER CHANGE-POINT ESTIMATION WITH RIGHT CENSORING IN LONGITUDINAL STUDIES.

Authors:  Xiaoying Tang; Michael I Miller; Laurent Younes
Journal:  Ann Appl Stat       Date:  2017-09       Impact factor: 2.083

10.  Medial temporal atrophy in early and late-onset Alzheimer's disease.

Authors:  Enrica Cavedo; Michela Pievani; Marina Boccardi; Samantha Galluzzi; Martina Bocchetta; Matteo Bonetti; Paul M Thompson; Giovanni B Frisoni
Journal:  Neurobiol Aging       Date:  2014-03-15       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.